UPharma Consulting rolls-out its brand-new series of pharmaceutical market access reports covering all Eastern European, Central Asian, South Caucasian, CIS, and other countries. The current Report—Ukraine Pharmaceutical Market Access Pathway 2020 FY ("Report")—is focused on Ukraine. The publication uncovers all aspects of accessing the market for pharmaceuticals: marketing authorization, pricing and reimbursement in Ukraine, essential medicines and national formulary listings, public purchase procedures, requirements, and stakeholders mapping, price regulation, health technology assessment.
UPharma Consulting launches its updated series of pharmaceutical country reports covering all Eastern European, Central Asian, South Caucasian, CIS, and other countries. The current Report—Ukraine Pharmaceutical Country Report 2020 FY ("Report")—is focused on Ukraine. This publication depicts the latest 2019-2020 FY business trends of Ukraine's pharmaceutical market, uncovers the market access pathway for pharmaceutical products in the country: from marketing authorization to essential medicines and national formulary listings. It provides a forecast of total pharmaceutical market sales for the next three years (2021-2023), considering all the COVID-19-concerned crisis implications.
The presented Report uncovers the 2019 business trends of the pharmaceutical market of Ukraine and provides the forecast of its development for the next three years (2020-2022) considering all implications related to the COVID-19-concerned crisis. The publication also provides the most recent insight into the country’s socio-political development, including the anticipations regarding the country's economic prospects in 2020-2022. The Report also overviews Ukraine's healthcare system, portrays its epidemiology (including COVID-19 statistics) and demographics. It also depicts pharma regulation features in Ukraine including a step-by-step process of the marketing authorization for pharmaceutical products.
NIS – Newly Independent States; CA – Central Asia. According to John Hopkins University Covid-19 has already killed over 80,000 people and infected 1.4 mln others globally as of the beginning of April 2020. Governments around the globe introduce efforts to fight the novel virus: from radical to very moderate. Some are already starting to weaken measures amid the risk of economic collapse. We accumulated key efforts done by the Ukrainian government to face this problem. This publication is a part of our regional NIS/CA Life Sciences Markets Monitor.Read more
This publication reveals the main characteristics of pharmaceutical regulation in seven CIS countries. It covers the issues of marketing authorization, import control, price regulation, and promotion of pharmaceutical products.Read more